ArticleBreast cancer research and treatment2018

Effectiveness and tolerability of neoadjuvant pertuzumab-containing regimens for HER2-positive localized breast cancer.

Laura Spring et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.